Collectively, our findings reveal a novel molecular mechanism involving the mito-ROS/OPA1/caspase-3/GSDME pathway in environmentally-induced PD-like pathology, thereby offering potential therapeutic insights for PD treatment. Here, OPA1 is linked to Parkinson disease.